BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.2.1//EN TZID:Asia/Jerusalem X-WR-TIMEZONE:Asia/Jerusalem BEGIN:VEVENT UID:1332@biology.technion.ac.il DTSTART;TZID=Asia/Jerusalem:20251224T123000 DTEND;TZID=Asia/Jerusalem:20251224T140000 DTSTAMP:20251209T121815Z URL:https://biology.technion.ac.il/en/seminars/bridge-to-industry-dr-rami- skaliter-cellcure-neurosciences-ltd/ SUMMARY:Bridge to Industry - Dr. Rami Skaliter\, Cellcure Neurosciences Ltd [No Categories] DESCRIPTION:Location: Faculty Of Biology Auditorium Dr. Rami Skaliter\n Af filiation: Cellcure Neurosciences Ltd\n Host:Dr. Dror Melamed\n You are in vited to the Sixth lecture in the "Bridge to Industry" series:\n\n \;\ n\nInsights from Developing Novel Allogeneic Cell Therapies for Serious Ne urological and Ophthalmic Diseases\nSpeaker: Dr. Rami Skaliter\, CEO of Ce llucure Neurosciences Ltd\n\n \n\nDr. Skaliter has an extensive career in the life sciences and pharmaceutical industries\, specializing in drug de velopment. He holds a B.Sc. in Biology from Ben-Gurion University and an M .Sc. and Ph.D. in Biochemistry from the Weizmann Institute\, where he focu sed on DNA replication and mutagenesis. After completing a postdoctoral fe llowship at Stanford University\, he transitioned into the biotech industr y.\n\n \;\n\nHe currently serves as the CEO of Cell Cure Neurosciences \, an Israeli subsidiary of Lineage Cell Therapeutics\, dedicated to devel oping and manufacturing pluripotent stem cell–derived therapies for dege nerative eye diseases and other neurodegenerative conditions. Previously\, he spent more than 20 years in key roles at Quark Pharmaceuticals\, inclu ding a decade as Chief Operating Officer.\n\n \;\n\nAt CellCure\, he l eads the development of scalable GMP manufacturing processes for allogenei c cell therapies\, including RPE cells for Dry AMD (in collaboration with Genentech/Roche) and auditory neuron progenitors for Auditory Neuropathy ( in partnership with Demant)\, alongside additional therapeutic programs. H e has been a speaker at major industry conferences\, presenting on cell th erapy formulation\, immune rejection challenges\, and advancing stem cell –based therapies into clinical trials.\n\n \;\n\nDate: Wednesday\, D ecember 24\, at 13:00\nLocation: Biology Auditorium\n\nSchedule:\n12:30– 13:00 Coffee and light refreshments – Lobby outside the auditorium\n13:0 0–14:00 Seminar – Biology Auditorium\n14:00–14:30 Open discussion wi th the speaker on “Bridge to Industry” – Auditorium Lobby\n\n \; \n\nJoin us for a fascinating journey of discovery\, collaboration\, and i nnovation!\n\nClick here to register LOCATION:Faculty Of Biology Auditorium END:VEVENT BEGIN:VTIMEZONE TZID:Asia/Jerusalem X-LIC-LOCATION:Asia/Jerusalem BEGIN:STANDARD DTSTART:20251026T010000 TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:IST END:STANDARD END:VTIMEZONE END:VCALENDAR